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Abstract
Previous cytogenetic studies suggest that various rDNA chromosomal loci are not equally active in different cell types.
Consistent with this variability, rDNA polymorphism is well documented in human and mouse. However, attempts to
identify molecularly rDNA variant types, which are regulated individually (i.e., independent of other rDNA variants) and
tissue-specifically, have not been successful. We report here the molecular cloning and characterization of seven mouse
rDNA variants (v-rDNA). The identification of these v-rDNAs was based on restriction fragment length polymorphisms
(RFLPs), which are conserved among individuals and mouse strains. The total copy number of the identified variants is less
than 100 and the copy number of each individual variant ranges from 4 to 15. Sequence analysis of the cloned v-rDNA
identified variant-specific single nucleotide polymorphisms (SNPs) in the transcribed region. These SNPs were used to
develop a set of variant-specific PCR assays, which permitted analysis of the v-rDNAs’ expression profiles in various tissues.
These profiles show that three v-rDNAs are expressed in all tissues (constitutively active), two are expressed in some tissues
(selectively active), and two are not expressed (silent). These expression profiles were observed in six individuals from three
mouse strains, suggesting the pattern is not randomly determined. Thus, the mouse rDNA array likely consists of genetically
distinct variants, and some are regulated tissue-specifically. Our results provide the first molecular evidence for cell-type-
specific regulation of a subset of rDNA.
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Introduction
Mammalian ribosomal RNA genes are comprised of several
hundreds of transcription units clustered on a number of
chromosomal loci [1,2]. Cytogenetic studies showed that in
human, individual chromosomal rDNA loci were not equally
active in different cell types [3,4]. A similar observation was also
made with plant cells [5]. These studies raised the possibility of the
existence of regulatory sub-domains in the rDNA array and their
cell-type-specific regulation (for a review [6]).
Polymorphic variations in rDNA are well documented [7–15].
In mouse, restriction fragment length polymorphism (RFLP) was
noted in the 59-end of the rDNA unit and attributed to a variable
number of repeats in the non-transcribed spacer [16]. These
RFLPs belong to 2–3 independent linkage groups, which are
distributed on several chromosomes and stable among mouse
strains (i.e., inter-group sequence exchange is rare) [8,16,17].
However, attempts to identify subsets of rDNA, which are
regulated differentially among tissues, have not been successful.
Six polymorphisms in human 28S rRNA V5 region were identified
and used as markers for individual rDNA genes to investigate their
expression in different tissues, but no consistent tissue-specific
expression pattern wasobserved(e.g.,[18]).The abilityof identifying
rDNA variants is also hampered by the lack of genomic sequence
information of both human and mouse rDNA loci (e.g., in GenBank
Release 163, December, 2007, only one mouse rDNA transcription
unit has been sequenced in its entirety, i.e., [19]). This lack of
sequence information precludes employing computational and
bioinformatic methods to identify rDNA variants.
Another not-well-explored area in the regulation of rRNA
synthesis is its cell-type-specificity [6]. In multicellular organisms,
because of differentiation of cellular functions, some cells may
have different requirements for rRNA synthesis than others. Cell-
type-specific regulation of rRNA synthesis was first witnessed
during Xenopus oogenesis, in which the rDNA array was amplified
several thousand-fold to boost rRNA synthesis [20,21]. This
amplification is achieved by a rolling-circle mechanism, which is
both cell-type- and developmental-stage-specific [22].
PLoS ONE | www.plosone.org 1 March 2008 | Volume 3 | Issue 3 | e1843Our recent study of basonuclin suggests that rRNA transcrip-
tion is modulated by cell-type-specific factors [23–25]. Basonuclin
(BNC1, Bnc1, MGI) is a zinc finger protein with highly restricted
cell-type distribution–it is mainly expressed in keratinocytes and
the reproductive germ cells. BNC1 interacts with rDNA promoter
and influences Pol I transcription (for reviews, [26,27]). We
reported that in BNC1-deficient oocytes only a subset of Pol I
transcription foci was affected [23]. The selective effect of BNC1-
deficiency on Pol I foci suggests that cell-type-specific rRNA
regulation relates to usage of subsets of rDNA. This notion led us
to search for rDNA variants (v-rDNA). Here we report the
molecular cloning of seven v-rDNAs, and the characterization of
their copy numbers, sequence, epigenetic modification, and
expression profiles in multiple tissues.
Results
Cloning RFLP of the mouse rDNA
The RFLPs in the non-transcribed spacer region of rDNA were
noted three decades ago [8,9,28]. To identify rDNA RFLPs that
could be used in isolating potential rDNA variants (v-rDNA), we
examined the RFLPs of thirty restriction enzymes for their size
distribution and stability during organogenesis. For size distribu-
tion analysis, mouse liver genomic DNA (Strain CF1) was cut in
single or double restriction digestions and subjected to Southern
analyses (Fig. 1A). Three hybridization probes were used to
examine 1) the promoter and the transcript-leader region (referred
to as promoter-leader), 2) the 18S, and 3) 28S rRNA coding
regions (Fig. 1B). Some restriction digestions were not informative
(i.e., they cut at either too many or too few sites). Only the
informative digestions are shown in Fig. 1. In general, the
promoter-leader region contained many RFLPs (Fig. 1A) and the
number of RFLPs varied from two to seven (e.g., Fig. 1A lanes 4
and 8, respectively). In contrast, the rRNA coding regions (18S
and 28S) contained no RFLP, i.e., the fragment size predicted by
the known sequence (BK000964) agreed well with the size of the
bands (Southern data not shown but summarized in Fig. 1B,
black lines). These Southern analyses confirmed previous conclu-
sions that most of the RFLPs were near the transcription start site
or up-stream from it (Fig. 1B, gray area).
The rDNA RFLPs were stable among individuals of inbred
strains [17]. However, the stability of the RFLPs within an
individual (i.e., during development and organogenesis) had not
been examined before. Accordingly, genomic DNA was isolated
from various tissues (spleen, kidney, testis, liver, intestine and skin)
of five unrelated CF1 mice (two females and three males) and
analyzed by Southern blots (Fig. 1C). To ensure sensitivity in
detecting variations, each of the four restriction enzymes used for
the Southern analysis produced at least four RFLPs. This analysis
showed no RFLP variability at the rDNA promoter among tissues
of the same individual, suggesting no recombination among rDNA
RFLPs during organogenesis. Taken together, our results agreed
well with a previous study [17] that rDNA recombination among
non-homologous chromosomes is rare and that rDNA contains
genetically stable variants (v-rDNA).
To identify and characterize sequence variations that were
uniquely associated with each type of v-rDNA, we identified a Bcl
I-Pst I fragment that contained the transcription start site (TSS)
and the surrounding 6 kb sequence (Fig. 1D). Southern analysis
showed that in the CF1 mouse strain there were at least three
groups (A, B and C) of the Bcl I-Pst I RFLPs ranging from 6.2 to
7.8 kb (Fig. 1E). To clone these RFLPs, the Bcl I/Pst I-digested
CF1 genomic DNA was size-fractioned on an agarose gel. From
the bands indicated in Fig. 1E, three libraries (A, B, C) were
constructed, which were then screened with a promoter-leader
probe by colony hybridization. Five, 8 and 20 positive clones were
identified from libraries A (8.0 kb), B (7.3 kb) and C (6.0 kb),
respectively. Restriction analysis by four enzymes (Bsp E1, Bsr GI,
Pvu II and Stu I) revealed that these 33 cloned RFLPs belonged to
seven distinct types of v-rDNA, named Type I through VII
(Table 1). Types I through V were isolated from library C, VI
from A, VII from B. To assess how well the genomic RFLP was
represented by the cloned v-rDNA, each clone was digested with
Bsp EI, which generated an internal fragment (Fig. 1D), and the
resulting pattern was compared with that of the genomic Bsp EI
RFLP in Southern analyses (Fig. 1F, Lane G). The results showed
that the cloned rDNA corresponded well to the genomic RFLP,
with the exception of one band with low copy number (Fig. 1F,
Lane G, arrowhead).
Copy number of mouse v-rDNA
To assess the size of the rDNA pool detected by our Southern
analysis, we measured the copy numbers of the Stu I and Sty I
RFLPs using a set of markers (Fig. 1A lanes 1, 2 and 3,
representing 100, 10 and 1 copies, respectively). The copy number
of Stu I RFLPs (Fig. 1A, Lane 10) was: a, 19; b, 2; c, 22; d, 12 (a
total of 55 copies). Similarly, the copy-number of Sty I RFLPs
(Fig. 1A, Lane 11) was: a, 14; b, 7; c, 21; d, 11; e, 16; and f, 14 or a
total of 83 copies. This analysis suggested we were examining an
rDNA pool of less than 100 copies, which fell short of the
estimated several hundred copies of rDNA in the mammals. Thus
we were likely dealing with a subset of the total rDNA
complement.
With the aid of the cloned v-rDNA fragments the genomic copy
number of each v-rDNA type was assessed. The assessment was
based on our ability to match the genomic RFLP with the
restriction fragment produced by each clone (Fig. 1F, Fig. 2A, B,
C). We screened twelve restriction enzymes that cut internally
within the cloned v-rDNA fragments and selected three (Bsp E1;
Nla III and Nsp I) for this analysis (Fig. 2A, B, C). No restriction
enzyme digestion could separate v-rDNA IV and V and they were
measured together. To increase the accuracy of the measurement,
copy number markers of different molecular weight (Fig. 2A) were
included in the Southern analysis to control for the variable
diffusion rate of different fragment size in the gel, which resulted in
a faster loss of smaller DNA from the gel during electrophoresis.
Quantification of the genomic RFLPs was based on three standard
curves covering the high, medium, and low molecular weight
ranges of the RFLPs (Fig. 1D). The copy number analyses
(Fig. 1E) demonstrated that all variant types were present in
similar copy numbers and that the total copy number of the rDNA
pool analyzed by this method was between 49 to 82, in agreement
with the Stu I- and Sty I-RFLP copy number analyses (Fig. 1A).
Sequence of v-rDNA
A total of 26 v-rDNA clones were sequenced, representing
approximately one third (26/73) of the estimated copies of the
rDNA pool studied here, i.e., individually, for I+II, 29% (8/28);
III, 33% (4/12); IV, 33% (4/12); V, 50% (2/4); VI, 44% (4/9) and
VII, 50% (4/8) )(Genbank accession numbers are given in Table
S1. Sequencing more clones would likely risk repeat sampling. The
promoter and transcribed regions were sequenced in their entirety.
The enhancer region was sequenced from both ends and due to
priming difficulty in repetitive sequence, a gap of 100–200 bp was
left at the center of the enhancer region (Fig. 3A). These
sequences confirmed that v-rDNAs had an enhancer region of
variable size (Fig. 3A), which was the main cause of RFLPs in the
promoter region [17,29–32]. Within each enhancer region, the
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from the sequence and the size of the PCR amplicon of the
enhancer region (Fig. 3A). Multi-sequence alignment analysis of
the transcribed region (+1t o+2000) revealed single nucleotide
polymorphisms (SNPs), some of which were variant-specific and
could be used to distinguish the transcript from each v-rDNA type
Figure 1. Molecular cloning of rDNA variants from CF1 mouse. A, An example of rDNA RFLPs revealed by Southern analyses of CF1 liver
genomic DNA. The Southern blot was probed with a DNA fragment from the promoter-leader region of rDNA. A molecular weight marker (mw) is
included (lane 5) and the molecular weights indicated to the left. Bands of size predicted by the published rDNA sequence (BX000964) are indicated
by arrowheads. A serial copy number marker is indicated by the copy numbers each band contains (i.e., 100, 10, 1). The copy number was calculated
as described in Tian et al., 2001, using 2.7610
9 bp for the haploid mouse genome. The fragments, whose copy numbers were assessed and described
in the text, are alphabetically labeled (lanes 10 and 11). The restriction enzymes used to generate A are the most informative among the thirty
enzymes tested. They are listed as they appear in B (i.e., lane 1, BamHI, lane 2, Bgl II, with the exception of lane 5). B, A summary of the RFLPs detected
by the Southern analyses. A generic rDNA (partial) is depicted in the middle, with transcription start site (bent arrow), the coding sequence (18S and
28S) and the hybridization probe (hammers) indicated. The polymorphism or lack thereof is depicted by circle-ended grey lines and black lines,
respectively. The number of polymorphisms for a given restriction fragment is shown in parentheses. The gray area indicates the variable region
around the transcription start site. C, The promoter region RFLP is stable during organ development. Genomic DNA was isolated from tissues of five
unrelated mice, three males (M1, 2 and 3) and two females (F1 and 2) and analyzed by Southern blots. Tissue genomic DNAs were digested with one
of the four enzymes (Bsp E1, Stu I, Sty I and NgoM IV) as indicated to the left of the gel image. The blots were probed with the same rDNA promoter
fragment as shown in A. SP, spleen, K, kidney, T, testis, L, liver, I, intestine, SK, skin. Note that no variation is detected among the tissues of an
individual. D, A restriction map indicates the cutting sites of relevant enzymes. The thicker line depicts the target fragment for cloning. The indicated
size (,6 kb) is that predicted by the published sequence. E, Liver genomic DNA was double-digested with Bcl I and another restriction enzyme and
probed with the promoter-leader probe. Bcl I-Pst I digestion yielded three groups of bands, which were purified individually by size-fractionation and
used to generate libraries designated A, B and C, respectively. F, Seven variant rDNAs (v-rDNA) were cloned and each contained an internal BspE1
fragment (lanes 1 to 7) that matched a BspE1 RFLP of the genomic DNA (lane G). When mixed as a group, the BspE1 digestion pattern of these v-
rDNA clones (lane 8) resembles that of the genomic digestion (lane G). Note one v-rDNA RFLP was not isolated (band E, arrow head in lane G).
doi:10.1371/journal.pone.0001843.g001
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classification of the v-rDNA and delineated the relationships
among the types (Fig. 3C). Type I and II v-rDNAs were
apparently very closely related and indistinguishable from each
other (Fig. 3C). These two types were also better related to the
known rDNA sequence (BK000964) than the other v-rDNAs
(Fig. 3C).
Genetic and Epigenetic variations in the v-rDNA
promoter
Within the promoter region (+1t o2300) of the seven v-rDNAs,
only two nucleotide substitutions were present (Fig. 4A), which
classified the promoters into three classes. Compared with the
consensus, Class 1 promoters (I, II and IV) contained at 2179 a C
to G transversion. Class 2 promoters (III and VI) contained a C to
A transversion at 2219. Class 3 was the consensus sequence.
Interestingly, both transversions occurred within CpG sites. At
2179, the C to G transversion shifted the CpG one nucleotide up-
stream, whereas at 2219, the C to A transversion abolished a
CpG site. Such genetic variations prompted us to examine DNA
methylation of the v-rDNA promoters.
Table 1. Classification the rDNA variants.
Bsp E1
1 (kb) BsrG1
2 Pvu II
3 (kb) Stu I
4
I2 . 9 + 0.60 -
II 2.8 + 0.60 -
III 2.9 - 0.75 +
IV 2.6 - 0.60 -
V2 . 6+ 0.60 -
VI 1.9 + 0.60 +
VII 3.9 - 0.75 +
1.Length of the Bsp E1 fragment containing the transcription initiation site (+1).
See also Fig. 1D.
2.The presence (+) or absence (2) of the BsrG1 site at 2519.
3.The length of the Pvu II fragment containing the transcription initiation site.
4.A Stu I site at 21200, which is not present in the previous published sequence
(BK000964).
doi:10.1371/journal.pone.0001843.t001
Figure 2. Copy numbers of v-rDNA. Measurements are based on RFLP of three restriction enzymes, Bsp E1 (A), Nla III (B) and Nsp I
(C). The genomic fragment of each v-rDNA was identified by its clone digested with the same restriction enzyme (e.g., Fig. 1F) and the identity is
indicated on the right of each Southern image. In A, copy number markers (1, 10 and 100 copies) of high (v-rDNA VI), medium (v-rDNA I) and low (v-
rDNA VII) molecular weights were included on the right of the genomic DNA (G) In B and C, the identification markers, which are generated by
digesting a mixture of cloned v-rDNA (cM), are shown to the right of the genomic DNA. m, molecular weight markers. D shows, as an example, the
quantification of Bsp E1 RFLP. Three standard curves and their mathematical descriptions are shown; H, high-, M, medium- and L, low-molecular
weight range. The density measurement of each RFLP band is mapped onto the standard curve of the appropriate molecular weight range. E,A
summary of the copy number measurements. The copy numbers are rounded to the next integer. The Roman numerals in the parenthesis indicate
the RFLPs that cannot be separated by gel electrophoresis. The average copy number was calculated from unambiguously identified RFLPs only. For
the Nla III digestion, one RFLP had no corresponding v-rDNA clone (*). The total copy number of Nla III RFLP is estimated without this RFLP (i.e., 49) or
with (i.e., 57).
doi:10.1371/journal.pone.0001843.g002
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MspI sites (at 2144, 2179 and 2261), which were used to assess
the DNA methylation status of the promoters (Fig. 4B, C, D, E).
The lack of sequence divergence within the v-rDNA promoters
precluded the possibility of selectively PCR-amplifying each
promoter via variant-specific primers. Instead, v-rDNA promoters
Figure 3. Structure and sequence variation in v-rDNA. A, A generic rDNA promoter is depicted at the top, showing the transcription start site
(bent arrow), the enhancer (boxes), the 59 external transcribed spacer (ETS) and its leader. Gray area represents the region sequenced. DNA
sequencing and PCR analysis showed that the RFLPs around the promoter are due, in part, to the variable size of the enhancer. Because of
uncertainties associated with aligning repetitive sequence, the size of the enhancer region was verified by PCR with primers flanking the region
(circle-ended arrows). The resulting PCR fragments are shown in the gel panel, in which the templates (cloned v-rDNA) are indicated above each lane.
The number of repeats in each enhancer region was estimated (black blocks, each represents one unit). Some units are partial as evidence in their
DNA sequence. B, Multi-sequence alignment reveals variant-specific SNPs in the transcribed region (59-ETS). The sequences (+1t o+2000) of the 26 v-
rDNA clones are aligned with the known rDNA sequence BK000964. Only a segment of the alignment (+407 to +475) is shown as an example. The
nucleotides identical to all v-rDNAs are displayed as white letters in a gray background, the variable nucleotides as gray letters in a white background
and the variant-specific nucleotide as white letters in a black background. Listed at the bottom of the alignment is the consensus sequence. C, The
same alignment is displayed as a dendrogram to show the genetic distance among the v-rDNA types.
doi:10.1371/journal.pone.0001843.g003
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PLoS ONE | www.plosone.org 5 March 2008 | Volume 3 | Issue 3 | e1843Figure 4. SNPs and DNA methylation of the v-rDNA promoters. A, Two SNPs define three classes of rDNA promoter. A generic rDNA
promoter is depicted at the top and the location of the SNPs (bold letters in the sequence) is shown below. The v-rDNAs associated with the SNP are
indicated on the left of the sequence and the promoter classification on the right. Transcription start site (bent arrow), cis-elements (grey sections),
HpaII sites (banners) and CpG islands (diamond-headed pins). B, The methylation status of the CpCpGpG was examined by Hpa II and Msp I
digestions followed by PCR amplification of the fragment containing the cut site. Hpa II-resistance indicates methylation at the CpG within the site,
where as MspI-resistance indicates CpC methylation. Three PCRs were designed to examine the Hpa II/Msp I sites at 2144, 2179 and 2261 using
primers indicated in (A). The PCR primers (circle-ended arrows) share an anchor primer (*) and the other primers determine whether the PCR
examines one, two or three HpaII sites as indicated by the boxed number in (A). The number of Hpa II sites examined is indicated on the right of the
gel panel in (B). The variant types examined are listed on top and restriction enzymes used below each lane. For each DNA sample, three digestions
were performed. b, bovine serum albumin (no digestion control), h, Hpa II and m, Msp I. C, The results in (B) were verified by quantitative PCR (qPCR,
n=2), in which the quantity of amplified genomic sequence is assigned as 1.0. D and E, Cytosine-methylation at other sites was evaluated by bisulfite
sequencing. Genomic DNA from liver (D) and testis (E) was digested by Bsp I (D) or Nsp I (E) and six v-rDNA types were isolated based on their co-
migration with the cloned v-rDNA digested with the same restriction enzyme. The genomic DNA served as a reference. Randomly picked rDNA
promoters were sequenced from either strands (above and below the line) and cytosine methylation data are aligned with a generic rDNA promoter
depicted on the top of the panel. Black circle, methylated, open circle, unmethylated, gray circle, methylation of non-CpG (e.g., CpC sites).
doi:10.1371/journal.pone.0001843.g004
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Fig. 2C). Mouse liver and testis genomic DNAs were digested
with Bsp E1 or Nsp I and electrophoresed alongside a v-rDNA
clone digested by the same restriction enzyme. The cloned v-
rDNA served as a marker for the mobility of their genomic
counterpart. The promoter region of individual v-rDNA (or two
when they could not be separated) was purified from the gel slice
and digested with Hpa II or Msp I. The Hpa II/Msp I-sensitivity
of each CpCpGpG was examined by PCR using primers
amplifying one, two, or all three CpCpGpG sites (Fig. 4A).
Consistent with previous reports, genome wide, about 50% of all
rDNA promoters were Hpa II-resistant at all three sites, suggesting
they were methylated at the CpG (Fig. 4B). Regular and
quantitative PCR (qPCR) showed all seven v-rDNA were
hypomethylated at all three Hpa II sites, and a slight increase in
CpC methylation of Hpa II site at 2144 (Fig. 4C). Bisulfite
sequencing analysis confirmed that genomic DNA contained two
types of rDNA promoters, one that was methylated at virtually all
CpG sites and one that contained only a few methylated CpG sites
(Fig. 4D, E, genomic). Notably, in the randomly selected genomic
rDNA clones, on average only 17% (2/16 in liver and 3/14 in
testis) were fully unmethylated, which was much lower than the
value (,50%) revealed by the HpaII/MspI sensitivity assay
(Fig. 4B). Bisulfite sequencing analysis also showed hypomethyla-
tion at all CpG sites in the promoter of identified v-rDNAs in
mouse liver (Fig. 4D) and testis (Fig. 4E). In these v-rDNA
promoters only sporadic CpG methylation was seen. Also detected
was methylation of several non-CpGs (Fig. 4D and E, gray
circles), including CpC methylation, which was considered rare
and only present in the embryonic stem cells [33]. These data
suggested that the seven v-rDNAs belonged to the hypomethylated
portion of the genomic rDNA complement and they were likely
transcribed.
Variant-specific PCR assays
Multi-sequence alignment showed variant-specific SNPs in the
transcribed region of v-rDNA (Fig. 3B). Statistical analysis of the
SNPs in the 26 v-rDNA clones confirmed the specificity of these
SNPs and suggested that by employing two such SNPs, highly
specific PCR assays could be developed for each v-rDNA type
(Table 2). Based on these observations, we developed a set of
variant-specific PCR assays. The variant-specific SNPs were
examined for their specificity and location within the transcribed
region. Six sets of SNPs were chosen to design the PCR primers
(Table 2, Fig. 5A and Methods S1). In these PCR primers, the
SNPs were the 39 nucleotide matching to the sequence of its
targeted v-rDNA. An exception was that for the 39 primer of v-
rDNA III, the specific nucleotide was in the middle of the primer
(Methods S1). The primers were also selected to flank the first
excision site of the pre-rRNA [34] to ensure amplification of only
the full-length transcript (Fig. 5A). Using the cloned v-rDNA as
templates, the PCR conditions were optimized so that each
reaction amplified its intended target v-rDNA with high specificity
(Fig. 5B). The sequences of v-rDNA I and II were very closely
related and no primer could distinguish them and these two v-
rDNA types were assayed together. Using the cloned v-rDNA as
templates, the efficiencies of the variant-specific PCRs were
adjusted to be similar. Some of these reactions (i.e., I+II, IV, V,
VI) were adapted for a real-time PCR assay by adding SYBR
green to the PCR reaction (Fig. 5C). Other reactions (i.e., III and
VII) could not be adapted because their specificity deteriorated in
the presence of SYBR, i.e., delta-Ct value for specific and non-
specific templates was less than 10.
Expression profile of v-rDNA in the mouse tissues
We used the variant-specific PCR assay to assess the expression
level of each v-rDNA (Fig. 6A). Total RNA was prepared from
common or gender-specific tissues of unrelated male and female
CF1 mice. Based on semi-quantitative RT-PCR (random
priming), the level of expression of the seven v-rDNAs could be
classified into three groups. Variants I, II and IV were expressed
universally (i.e., in all tissues examined), but the expression level of
IV appeared to vary significantly in different tissues, suggesting
expression modulation. In contrast, transcripts of V and VII were
never detected in the 30 tissues examined. Interestingly, transcripts
from III and VI were detected only in a limited number of tissues
(Fig. 6A). Overall, most tissues contained three v-rDNAs (i.e., I, II
and IV), but brain and testis contained five (i.e., I, II, III, IV and
VI). Similar v-rDNA expression profiles were detected in
individuals from mouse strains 129Sv and C57BL/6 (Fig. 6B
and C), suggesting this profile was not individual- or strain-
specific.
Using quantitative PCR (qPCR), we investigated the relative
transcript level of each v-rDNA in brain, skin, and testis (Fig. 7A).
The relative level of rDNA expression was higher in the brain and
testis than that of skin. This study also suggested that in these three
tissues, each v-rDNA contributed similarly to the pre-rRNA pool.
This conclusion was confirmed when the level of v-rDNA
transcripts was normalized against the level of the 47S pre-rRNA.
Interestingly, the sum of the five v-rDNAs (i.e., I, II, IV, V and VI)
could account for no more than 75% of the 47S pre-rRNA. Of the
two v-rDNAs (i.e., III and VII) that were not measured because of
technical difficulties, III was expressed at a low level and VII was
not expressed at all (Fig. 6). Thus neither v-rDNA could make up
the missing 25% of the pre-rRNA transcript. This observation
suggested contributions from yet identified v-rDNAs.
We also investigated the relationship between expression level
and gene copy number of variants IV and V in the testes of
129Sv/C57BL-6J hybrid mice. Variant IV was highly expressed
whereas V was virtually silent. Furthermore, their PCR assays had
similar amplification efficiency (Fig. 7C). Testes of two 129Sv/
C57BL-6J mice were isolated; one of the testes from each mouse
was used for RNA extraction and the other for genomic DNA
isolation. Quantitative PCR showed that the average Ct value for
v-rDNA IV transcript was 18.362.1 and that for v-rDNA V was
greater than 40 (below background), which translated into at least
2
21.7 or 3.7610
6-fold difference. The same assay showed that the
Ct value of genomic v-rDNA IV was 25.362.1 and that of v-
rDNA V 27.162.4, an approximately 4-fold difference
(2
1.8=3.48). The ratio of Ct values of RNA and DNA suggested
that for each copy of v-rDNA IV there were 128 transcripts (i.e.,
47S pre-rRNA), whereas no transcript was detected for v-rDNA
V. This result demonstrated that the variations in expression level
could not be explained by copy number alone, and thus
differential transcription modulation or post-transcription process-
ing should be considered.
Discussion
Based on the data presented here, we propose that mouse rDNA
array contains several variant types. The expression of each
variant appears to be regulated independently from others and for
some variants (i.e., III and VI), expression is tissue-specific. We
describe several lines of evidence to support this proposal. Guided
by the stable rDNA RFLPs, we cloned seven v-rDNAs; copy
number analyses suggest that most variants contain between 8–15
copies; we identified variant-specific SNPs in the transcribed
sequence and variant-specific PCR revealed variable expression of
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are conserved within and among mouse strains.
Our results are consistent with previous reports on the v-rDNA
RFLPs. A previous study used two restriction enzymes (Eco RI
and Hind III) to examine six inbred CBA/H-T6 individuals and
found no variation in their rDNA RFLPs [8]. In addition, our
study detected no variation among tissues of an individual
(Fig. 1B). Taken together, these results indicate that non-
homologous sequence exchanges (homogenization) among differ-
ent mouse v-rDNAs are rare [17]. By molecular cloning of seven
rDNA RFLPs, we were able to measure their genomic copy
numbers. This measurement suggests that the v-rDNAs described
here are a subset of the mouse rDNA array. Measurement of the
intensity of hybridization signal indicated consistently a total copy
number of between 50 to 80, which falls short of the estimated
several hundreds copies of rDNA in mouse [35]. This discrepancy
may in part be explained by the inherent difficulty in assessing
copy numbers by hybridization, which depends on sequence
homology. Any sequence variation between the probe and targets
may result in reduced hybridization, and hence an underestima-
tion of the copy number. Furthermore, our method also favors
detecting rDNA configured as tandem repeats and likely
underestimates rDNA in other configurations (e.g., single copy
of varying size or inverted repeats), which are present in the
mammalian rDNA array [14,15].
The DNA methylation status of the v-rDNA also suggests that
we are dealing with a subset of rDNA. DNA methylation
measurements by HpaII sensitivity as well as by bisulfite
sequencing showed that the promoters of the seven v-rDNAs are
hypomethylated, whereas the same method detected hypermethy-
lated rDNA promoters in the genome. Furthermore, bisulfite
sequencing suggested that ,17% of the mouse genomic rDNA
Table 2. Variant-specific single nucleotide polymorphism.
Type clone I-5* I-3 III-5 III-3 IV-5 IV-3 V-5 V-3 VI-5 VI-3 VII-5 VII-3
I I-A ATACATGTGCCT
I-B ATACATGTGCCT
I-C ATACATGTGCCT
I-D ATACATGTGCCT
I-F ATACATGTGCCT
I-D ATACATGTGCCT
II II-A ATACATGTGCCT
II-B ATACATGTGCCT
III III-A A C CTATGTGCCT
III-B A C CTATGTGCCT
III-C A C CTATGTGCCT
III-D A C CTATGTGCCT
IV IV-A G C A C GGGTGCCT
IV-B A C A C AGGTGCCT
IV-C G C A C GGGTGCCT
IV-D G C A C GGGTGCCT
V V - A GCACGTTCTACT
V-B G C A C G T TCTACT
V I V I - A GCACATGTTCCT
V I - B ACACTTGTTCCT
V I - C ACACATTTTCCT
V I - D GCACGTTTTCCT
VII VII-A A C A C G T T T G C TC
VII-B T C A C A T T T G C TC
VII-C G C A C A T G T G C TC
VII-D A C A C T T G T G C TC
total 26 26 26 26 26 26 26 26 26 26 26 26
A1 7 02 2 01 7 0000200
C01 8 42 2 000202 4 2 2 4
G8000742 0 02 0 000
T180422 2 62 4 6042 2
p-value single 1.6E-02 6.4E-07 6.7E-05 6.7E-05 4.5E-02 6.7E-05 4.6E-02 3.1E-03 1.0E-03 7.1E-01 6.7E-05 6.7E-05
double 6.4E-07 6.7E-05 5.9E-03 3.1E-03 6.7E-05 6.7E-05
*The SNPs are named according to their use in the variant-specific PCR assay (e.g., V-5 means that the SNP is used in the 59 primer for assaying v-rDNA V). V-rDNAs I and
II are assayed by the same pair of primers.
doi:10.1371/journal.pone.0001843.t002
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these hypomethylated rDNAs obtained from random samplings
are the same that we obtained by RFLP-based cloning (i.e., the
50–80 copies of v-rDNAs), then the total copy number of rDNA in
the mouse genome would be between 294 to 471, which is
remarkably close to the estimated 300 to 400 copies of rDNA in
mouse. This and other analyses discussed below strongly suggest
that we are dealing with a subset of rDNA.
A related question is why we isolated only hypomethylated
rDNA. We speculate that our method can only detect v-rDNA
arrays that are arranged as tandem repeats (i.e., yielding a single
DNA fragment upon restriction digestion). On the other hand, if
the methylated rDNAs are in a different configuration or their
restriction fragment length varies from unit to unit, then restriction
digestion will produce a smear of bands on the gel, which would
not be identified and cloned by our method. A recent study of
human rDNA array did show rDNA units of variable length, as
well as existing in configurations other than tandem repeats (e.g.,
single copy outside rDNA clusters, or inverted repeat) [14,15].
Our speculation is only one of several possible explanations.
The copy number analysis also suggests that each type of v-
rDNA contains between 8–15 copies, which are arranged in
tandem (i.e., yielding restriction fragments of the same size). An
ambiguity is that we could not measure by Southern blot the copy
number of v-rDNA IV and V separately. However, qPCR
measurements suggest that their copy number ratio is 3.48
(Fig. 7C). Because their combined copy number measured by
Southern blot is on average ,16, this translates into that 12 IV
copies and 4 V copies. This estimate makes V the least abundant
v-rDNA, which is consistent with our isolating only two clones
from a total of 33 v-rDNA clones. Thus it appears that v-rDNAs
are blocks of tandem repeats of no more than 20 units. Whether
this block size is due to a limitation in stability of tandem repeats or
the regulatory requirement of rDNA remains to be investigated. It
is reasonable to assume that if each v-rDNA type is a cluster of
tandem repeats of no more than 20 copies, then the cluster is very
likely located at one chromosome locus.
The expression studies suggest that the v-rDNA types are
regulated differentially. The constitutively expressed v-rDNAs (I,
II and IV) represented approximately 56% of the copies of the v-
rDNA detected. The selectively expressed III and VI constitute
about 29% copies, in which VI is expressed more widely than III,
suggesting that they are individually regulated. The silent V and
VII have ,15% of the copies. Our data show that the three v-
rDNA regulatory groups are present in six mice of three strains,
which strongly suggest that their regulation is not randomly
determined. It should be noted that our analysis employs tissues
containing many cell types, each of which may have a unique
profile of v-rDNA expression. When assayed as a mixture, the
unique v-rDNA profile of each cell type may be obscured (i.e.,
being diluted or canceled out). Furthermore, our observation is
limited developmentally to a narrow window in adulthood.
Therefore, our results are likely an underestimate of the
complexity of v-rDNA regulation. This point is of particular
relevance in interpreting the apparent lack of expression of v-
rDNA V and VII. It remains possible that these v-rDNAs are
Figure 5. Variant-specific PCRs. A, Locations of the amplicons are shown in reference to the 59-ETS. The large arrow depicts transcription start site
and direction; asterisk, the first cleavage site in processing the pre-rRNA; small arrows, PCR primers; and the Roman numerals, PCR specificity. B, The
specificity of each variant-specific PCR was tested with cloned v-rDNAs. The PCR was also adjusted, using cloned v-rDNA, to have similar amplification
efficiency. Lowercase letters on top of the gel image indicate cloned templates, and uppercase letters to the left of image, the specificity of primers,
m, molecular weight marker. C, An example of the specificity of qPCR for variant IV is shown (SYBG fluorescence). The delta Ct between specific and
non-specific reactions is greater than 10.
doi:10.1371/journal.pone.0001843.g005
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developmental stage, and thus not detected by our screen.
Consistent with this proposal is that v-rDNA VII is expressed in
corneal epithelial keratinocytes [25]. Nevertheless, the over all
regulatory patterns are clear and indicate cell/tissue-specific
regulation of rRNA synthesis. Most important, these results
suggest that mammals possess regulatory mechanisms that
determine precisely which v-rDNA to express in different tissues.
Although our data do not discern how the regulation is achieved
(i.e., transcription or/and processing, or by yet unidentified
mechanisms) for the actively transcribed rDNA (i.e., hypomethy-
lated), a number of transcriptional and processing regulatory
mechanisms have been reported (for recent reviews, [35–40]. It is
possible that these mechanisms can exert their effect on a selective
subset of rDNA, but that has not been demonstrated. These
mechanisms are likely responsible for regulation of constitutively
Figure 6. Expression of v-rDNA in mouse tissues. Variant-rDNA expression was assessed by RT-PCR in mouse strain CF1, (A), 129Sv, (B) and
C57BL/6J, (C). A, RNAs from common and gender-specific tissues of one female and one male CF1 mice were assayed as indicated above the gel
image. For a given tissue sample, all variant-specific PCRs were performed with the same cDNA preparation. The primer specificity is indicated on the
left of the gel image. For each PCR, a set of controls was included to monitor the specificity (the left seven lanes) and the relative quantity and
integrity of the RNA preparation (beta-actin). To assure no toxicity was present to prevent amplification of v-rDNA V, the cloned DNA was mixed with
cDNA preparation before PCR (row +V). Similar results were obtained for VII (not shown). A PCR detecting all v-rDNA transcript (47S) is also included.
m, molecular weight markers, O, blank. B and C, as in A except that each assay included a set of CF1 RNA samples as a reference (the last three or four
lanes).
doi:10.1371/journal.pone.0001843.g006
Figure 7. Quantitative analysis of v-rDNA expression. A, RNA samples from two hbyrids (C57BL/129Sv) were assayed with qPCR, the
expression level was normalized with the transcript of beta-actin. (n=2). Note that because V was not detected, only three bars are visible. B,I n
another experiment, the v-rDNA expression level was normalized with the 47S pre-rRNA (represented by the full circle) to show the contribution of
each v-rDNA to the pre-rRNA pool. The values are average of two measurements. The blank sector is the portion of pre-rRNA not accounted for by
the v-rDNA transcripts. C, A comparison of RNA and DNA quantity ratios. Ct values of RNA and DNA are superimposed on the standard curves of the
two qPCRs for v-rDNA IV and V. Ct values of serial dilutions of cloned DNA (IV, black triangles; and V, open circles) are shown with the standard curve.
RNA (transcript) Ct values are shown by squares (IV, black). The value of v-rDNA V is out of range, thus not plotted, but the average and standard
deviation are indicated. Genomic DNA measurements are depicted as diamonds (IV, black and V, open). The average and standard deviation of 2
samples, each measured twice, are indicated by pins; circle-ended pins for variant IV and diamond-ended ones, V.
doi:10.1371/journal.pone.0001843.g007
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is responsible for the regulation of cell/tissue-specific expression.
Although our data do not provide a definitive answer, they do
suggest reasons for eliminating several possibilities. (i) We noted
that SNPs in the rDNA promoters appear to correlate with their
activity, e.g., Class I (G at 2179) correlates with constitutive
expression and Class 2 (A at 2219) correlates with selective
expression. However, these SNP markers are also present in
hypermethylated rDNA promoters, which are transcriptionally
silent. Therefore, the SNPs cannot be the sole determinants of
promoter activity. (ii) Copy-number is unable to account for the
variation of v-rDNA transcript level in different tissues. The
variants III and IV are present in similar copy numbers, but III is
selectively, whereas IV constitutively, expressed. (iii) Furthermore,
the variable expression pattern of v-rDNA among different tissues
is unlikely the result of promoter exchange via recombination
between non-homologues rDNA loci during organogenesis. This
conclusion is based on our observation that rDNA RFLPs are
invariable among tissues of the same individual. (iv) Mouse rDNA
is partitioned into transcriptionally active and silent blocks by
epigenetic modifications (i.e. DNA methylation and chromatin
modification) [41–47]. We detect in the v-rDNA VII promoter
(silent) cytosine methylation of CpG at 2133, which was shown to
block transcription [45]. This mechanism may explain the silence
of VII in most tissues. However, DNA methylation cannot explain
the tissue-specific expression of III and VI, because their
promoters are hypomethylated in both liver and testis, but their
expression is primarily detected only in the latter. (v) The variable
number of enhancers, which stimulates Pol I transcription [48–
50], may account for the silence of VII (3–4 enhancer units) and
the selective activity of VI (20 units). Nevertheless, this parameter
alone cannot explain the differential activity of IV (constitutively
active) and V (silent), which have similar numbers of enhancer
units (10 and 11). This analysis suggests yet unidentified
mechanisms in cell-type- and v-rDNA-specific regulation.
Our findings raise the question regarding the biological
significance of cell-type-specific regulation of v-rDNA, and the
developmental-stage-specific regulation of variant rRNA noted
previously in malaria parasites Plasmodium [51,52]. In mammals,
our finding is consistent with the ‘‘ribosome filter hypothesis’’
[53,54], which is based on observations that many mRNAs
contain sequence similar or complementary to the 18S rRNA. The
ribosome filter hypothesis proposes that differential binding of
particular mRNAs to eukaryotic 40S ribosomal subunits before
translation may selectively affect rates of translation. In this view,
ribosomal subunits themselves are considered regulatory elements
or filters that mediate interactions between particular mRNAs and
components of the translation machinery. These interactions
would depend, in part, on the complementarity between sequences
in mRNA and rRNA, as well as on structural differences among
ribosomes in different cell types. Thus, a major predication of the
ribosome filter hypothesis is that rRNA population is heteroge-
neous and different rDNAs are expressed with cell-type-specificity.
Our results support this prediction. The biological meaning of
cell-type-specific regulation of v-rDNA is also hinted from the
function of BNC1, which regulates a subset of rDNA [24,25].
Using a BNC1 knock-down model, we showed that Bnc1 is a
mammalian maternal-effect gene, i.e., embryos derived from
BNC1-deficient oocytes die at the 2-cell stage [23]. The maternal
effect of BNC1 is of particular interest because oocytes synthesize
and accumulate a large amount of rRNA during their growth,
presumably for use in early embryos, which depend entirely on
maternal ribosomes for their translational need [55–59]. It is
therefore paradoxical that in mouse a substantial amount of
maternal rRNA and ribosome are degraded during oocyte
maturation prior to fertilization [60,61]. This paradox is rooted
in the dogma of ribosome biology that for each species one type of
ribosome suffices. It is tempting to speculate that cell-type-specific
regulation of v-rDNA represents a differential requirement of
subtypes of ribosomes during development, e.g., upon maturation,
mouse oocytes degrade the ribosomes not required or detrimental
for embryonic development. This interpretation can also explain
BNC1’s maternal effect; BNC1 promotes production of a subtype
of ribosomes required for early embryonic development.
In summary, using rDNA RFLP, we identified seven rDNA
variants. Each variant appears to contain approximately 10 to 15
transcription units arranged as tandem repeats. The promoters of
the seven variant types are hypomethylated, which suggests that
they are transcriptionally active. We show by variant-specific
PCRs that these v-rDNAs are not regulated in concert, but
independently, and in some cases, tissue-specifically. Our results
provide the first molecular evidence of tissue-specific usage of a
subset of rDNA. In light of recent findings that human rDNA
transcription units are variable in length and arranged in a variety
of configurations [14,15], our observations also suggest heretofore-
unappreciated complexity in mouse rDNA structure and regula-
tion.
Materials and Methods
Mouse Strains CF1, 129Sv and C57BL/6J mice were purchased
from Charles River Laboratory and sacrificed on arrival. C57BL/
6J/129Sv hybrid mice were F4 progeny of a backcross of
129Sv:C57BL6C57BL [25]. The exact genetic contribution from
each strain was not well defined. The mouse experiments were
performed according to the protocols approved by University of
Pennsylvania Animal Care and Use Committee.
Southern analysis and the cloning of v-rDNA
Genomic DNA isolation, restriction digestion, Southern anal-
ysis, construction of libraries of size-fractionated genomic DNA
and colony hybridization were performed as previously described
[63]. The Southern probes were prepared by PCR using primers
derived from published sequences (GenBank BK000964 and
X82564) [19,62]. Each blot was analyzed by comparing the size of
the hybridizing fragments with that predicted by the known
sequence (Fig. 1A, B). To reduce the chance of partial digestion,
genomic DNAs were over-digested by more than 50-fold (i.e., the
amount of enzyme and the duration of digestion were sufficient to
digest 50-fold more substrate DNA). All hybridizations were done
at high stringency (i.e., hybridization at 65uC in 1M NaCl and
final wash at 0.26SSC at 65uC).
RNA analysis (RT-PCR and qPCR)
RNA isolation and RT-PCR analysis were performed as
previously described [64]. Variant-specific primers and PCR
conditions (primers and cycling parameters) are provided in the
supplementary materials (Methods S1. Quantitative PCRs were
done first on a DNA Engine OPTICON2 (MJ Research, MA)
with a kit (F-400RS/L, Finnzyme Oy, Espoo, Finland), and
repeated on an Applied Biosystems 7500 Real Time PCR,
following manufacturers’ instructions. Beta-actin mRNA and 47S
pre-rRNA were used as internal reference.
DNA sequencing was performed at PENN DNA Sequencing
Facility.Bisulfitesequencingwasdone with anEZDNA methylation
Kit (ZYMO Research Co., Orange, CA) following manufacturer’s
instructions. Sequence alignment was first performed by the
computer program Clustal-W implemented in Vector NTI (Invitro-
Variants of Mouse rDNA
PLoS ONE | www.plosone.org 12 2008 | Volume 3 | Issue 3 | e1843gen) or as a web-based program (http://bioinfo.genopole-toulouse.
prd.fr/multalin/) [65]. The machine alignments were then refined
manually.
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